Navigation Links
New Guidelines Recommend Opioids for Seniors' Pain
Date:5/7/2009

NSAID use for persistent aches needs to be curbed, Geriatrics Society says

THURSDAY, May 7 (HealthDay News) -- The use of non-steroidal anti-inflammatory drugs (NSAIDs) or cox-2 inhibitors to treat persistent pain in seniors should be drastically reduced, according to new pain management guidelines released this week by the American Geriatrics Society (AGS).

The original guidelines recommended the use of over-the-counter or prescription NSAIDs and cox-2 inhibitors such as aspirin or ibuprofen before seniors were prescribed an opioid drug to treat persistent pain.

But this is a risky strategy in older patients, because the cardiovascular, gastrointestinal and other risks posed by the drugs often outweigh the benefits, the authors of the new guidelines said. They said NSAIDs and cox-2 inhibitors should be used rarely, and with extreme caution, in highly selected patients.

All older patients with moderate to severe pain or diminished quality of life due to pain should be considered for opioid therapy, which may be safer for many patients than long-term use of NSAIDs, according to the updated guidelines.

"Because the most common strategy for management of persistent pain among older persons is the use of pharmacologic agents, and because this is also the area of greatest risk, we chose to focus on pharmacotherapy in this update," Dr. Bruce Ferrell, guidelines panel chair, said in an AGS news release.

"Since the two previous AGS publications, new drugs have been introduced and management strategies have been more fully evaluated, so we felt it was important to focus on pharmacotherapy in this update," Ferrell explained.

The new guidelines will appear in the August issue of the Journal of the American Geriatrics Society.

Persistent pain is common among older people. If ongoing pain is ignored or incorrectly treated, patients can suffer problems such as falls, sleep disruptio
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Board of Trade Issues Business Preparation Guidelines for H1N1 Virus Outbreak
2. American Slide Chart/Perrygraf "SlideGuides" and "SpinGuides" Help Drug Companies Satisfy New PhRMA Guidelines
3. EMPOWERx E-Prescribing Solution Provides Latest Treatment Guidelines for 2008-2009 H1N1 Influenza Virus
4. Video: CREON(R) (Pancrelipase) Delayed-Release Capsules First and Only Pancreatic Enzyme Product to Receive FDA Approval Under New Guidelines
5. T-System Releases Free Clinician Swine Flu Templates, Incorporating Updated CDC Interim Guidelines for Diagnosis and Treatment
6. Guidelines for medical home demonstrations released by major physician groups
7. Guidelines: Pregnancy Safe with Epilepsy, but Valproate Should be Avoided
8. An Innovative New Book Helps Consumers Find Out if Their Doctors are Following Official Treatment Guidelines
9. PDAs, more education help doctors follow cholesterol treatment guidelines
10. Cardinal Rigali Criticizes Draft NIH Guidelines for Destructive Stem Cell Research
11. NCCN Updates Kidney Cancer Guidelines to Incorporate FDA Approval of Everolimus
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Guidelines Recommend Opioids for Seniors' Pain
(Date:8/1/2014)... August 01, 2014 The Judicial Panel ... that testosterone replacement therapy caused strokes, heart attacks, and ... designated Judge Matthew F. Kennelly as the transferee judge ... to the Chicago-based federal court. , As one of ... of appointing committees of attorneys who will move the ...
(Date:8/1/2014)... HealthDay Reporter FRIDAY, Aug. 1, 2014 (HealthDay News) ... have significantly less endurance than those who weigh less, a new ... were obese, half were of normal weight -- people who were ... Obesity also was associated with less strength, increased discomfort and ... to 65 years of age -- neither improved nor reduced a ...
(Date:8/1/2014)... York, New York (PRWEB) August 01, 2014 ... http://www.gynecaremorcellatorlawsuit.com/ ) on behalf of women who allegedly experienced ... of power morcellators in gynecological surgeries, Bernstein Liebhard LLP ... to withdraw a number of power morcellators marketed by ... a report from The New York Times, some critics ...
(Date:8/1/2014)... Writing down fears, emotions and the benefits of a ... cancer survivors, according to a study conducted by a ... "The key to developing an expressive writing intervention is ... journal recording facts and events. Writing a journal can ... evidence to determine whether it,s effective or not," said ...
(Date:8/1/2014)... August 01, 2014 On Monday, June ... NextGen User Symposium in San Francisco, CA. Now in ... the JW Marriott Union Square hotel. , “We are ... up to speed with ACA compliance issues,” Quirk Healthcare ... The symposium provides attendees guidance with NextGen implementation and ...
Breaking Medicine News(10 mins):Health News:Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL 2Health News:Obesity Might Slow You Down at Work 2Health News:Obesity Might Slow You Down at Work 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 4Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3Health News:Quirk Healthcare Foundation Hosts Fifth Annual California NextGen User Symposium and Launches First Annual Florida NextGen User Symposium 2
... a 60-acre health and education complex in Islamabad to cater ... the capital and the twin city of Rawalpindi . ... plan to develop a Health and Education City in the ... medicine, nursing, and dentistry. ,Harvard Medical International ...
... and a standardized rehabilitation protocol are successful in returning ... today at the 2007 Annual Meeting of the American ... Center. ,Dr. Brunt and colleagues studied the ... to evaluate the experience of athletes undergoing tension-free mesh ...
... According to new research of the American Orthopaedic Society ... , Adaptive changes occur in the arm bone and ... in youth baseball and help protect them against injury. ... maintain external shoulder rotation as they mature, says principal ...
... criminalise the purchase of sex, a move that is proving ... will make sex workers more vulnerable . ,Men ... jail, pay a fine or face both, under proposed legislation ... law will outlaw the buying of sex, but not the ...
... Beckham is really wishing for, is a baby girl . ... and hubby David Beckham will try to add to their family ... be bringing back a bundle of pink from the hospital. ... is because after all those boys in the house, she would ...
... and Memory have uncovered a molecular mechanism that governs ... ,The work could lead to the first ... each year from persistent, debilitating fears - including hundreds ... ,A study conducted by the Army in 2004 ...
Cached Medicine News:Health News:Surgical Repair of Athletic Hernia Speeds Return to Play 2Health News:Surgical Repair of Athletic Hernia Speeds Return to Play 3Health News:Shoulder Protection by Throwing Motion in Baseball Players 2Health News:Prostitutes Fume as Norway Bids to Criminalise Sex Purchases 2Health News:Prostitutes Fume as Norway Bids to Criminalise Sex Purchases 3Health News:First Drug for Post-traumatic Stress Disorder 2
(Date:8/1/2014)... Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a ... used to develop, manufacture and sell enzymes and other ... enzyme industries, announced today that it will report its ... 2014 after market close on Thursday, August 14, 2014 ... 5:00 p.m. Eastern Time to discuss those results. ...
(Date:7/31/2014)... Indien, August 1, 2014 ... Inc. gaben heute bekannt, vor kurzem für ... zur Schmerzbehandlung nach chirurgischen Eingriffen eine kommerzielle ... der Europäischen Union und weiterer europäischer Länder ... und mit Ropivacain gefüllte OneDose ReadyfusOR später ...
(Date:7/31/2014)... Calif., July 31, 2014 STAAR Surgical Company ... and marketer of implantable lenses and delivery systems for ... ended July 4, 2014 of $20.0 million, a 10% ... of 2013. On a constant currency basis, revenues grew ... the second quarter of 2013.  The effect of foreign ...
Breaking Medicine Technology:Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 2Cipla und BioQuiddity geben EU-Geschäftspartnerschaft für OneDose-ReadyfusOR zur Schmerzbehandlung nach chirurgischen Eingriffen bekannt 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25STAAR Surgical Reports 10% Second Quarter Revenue Growth 26STAAR Surgical Reports 10% Second Quarter Revenue Growth 27STAAR Surgical Reports 10% Second Quarter Revenue Growth 28STAAR Surgical Reports 10% Second Quarter Revenue Growth 29STAAR Surgical Reports 10% Second Quarter Revenue Growth 30STAAR Surgical Reports 10% Second Quarter Revenue Growth 31
... 2010 /PRNewswire-- Sangart, Inc., a global biopharmaceutical ... to enhance the perfusion and oxygenation of ischemic ... gas delivery, today announced that its investigational biopharmaceutical ... by the U.S. Food and Drug Administration (FDA) ...
... A new electronic health record (EHR) safety reporting ... not-for-profit organization composed of medical society and professional liability ... Network. EHRevent.org establishes a national system where ... related to the implementation and use of EHRs. ...
Cached Medicine Technology:Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 2Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 3New National Electronic Health Record Safety System Launched 2New National Electronic Health Record Safety System Launched 3New National Electronic Health Record Safety System Launched 4New National Electronic Health Record Safety System Launched 5New National Electronic Health Record Safety System Launched 6
The Bofor acetabular revision cup addresses cases of severe acetabular destruction....
The Protract stem offers a press-fit option which will allow choice of standard or lateralized neck offsets while keeping a consistent leg length....
Performa uncemented stem....
M2 cemented hip stem....
Medicine Products: